Abstract
This study aimed to investigate if the human fetus can form epoxides during the oxidation of double bonds. Indirect evidence for this was obtained using 4,16-androstadien-3-one as substrate o f the liver microsomal drug oxidation enzyme system. Human fetal liver microsomes were shown to catalyze the formation of the corresponding 16,17-glycol, a reaction that is thought to proceed via an intermediary 16,17-epoxide. The findings may imply that the human fetus is also capable of forming epoxides from certain drugs that contain double bonds.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 833-839 |
| Number of pages | 7 |
| Journal | Clinical Pharmacology and Therapeutics |
| Volume | 14 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1973 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Formation of a 16,17-trans-glycolic metabolite from a 16-dehydro-androgen in human fetal liver microsomes'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS